163 related articles for article (PubMed ID: 31432137)
1. MicroRNA‑217 is involved in the progression of atherosclerosis through regulating inflammatory responses by targeting sirtuin 1.
Zhang L; Chen J; He Q; Chao Z; Li X; Chen M
Mol Med Rep; 2019 Oct; 20(4):3182-3190. PubMed ID: 31432137
[TBL] [Abstract][Full Text] [Related]
2. Effects of microRNA‑217 on high glucose‑induced inflammation and apoptosis of human retinal pigment epithelial cells (ARPE‑19) and its underlying mechanism.
Xiao H; Liu Z
Mol Med Rep; 2019 Dec; 20(6):5125-5133. PubMed ID: 31702814
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA‑217 inhibition relieves cerebral ischemia/reperfusion injury by targeting SIRT1.
Rao G; Zhang W; Song S
Mol Med Rep; 2019 Aug; 20(2):1221-1229. PubMed ID: 31173187
[TBL] [Abstract][Full Text] [Related]
4. miR‑217 and miR‑543 downregulation mitigates inflammatory response and myocardial injury in children with viral myocarditis by regulating the SIRT1/AMPK/NF‑κB signaling pathway.
Xia K; Zhang Y; Sun D
Int J Mol Med; 2020 Feb; 45(2):634-646. PubMed ID: 31894309
[TBL] [Abstract][Full Text] [Related]
5. microRNA-212 promotes lipid accumulation and attenuates cholesterol efflux in THP-1 human macrophages by targeting SIRT1.
Miao H; Zeng H; Gong H
Gene; 2018 Feb; 643():55-60. PubMed ID: 29174964
[TBL] [Abstract][Full Text] [Related]
6. Salidroside attenuates oxidized low‑density lipoprotein‑induced endothelial cell injury via promotion of the AMPK/SIRT1 pathway.
Zhao D; Sun X; Lv S; Sun M; Guo H; Zhai Y; Wang Z; Dai P; Zheng L; Ye M; Wang X
Int J Mol Med; 2019 Jun; 43(6):2279-2290. PubMed ID: 30942428
[TBL] [Abstract][Full Text] [Related]
7. miR-217 inhibits the migration and invasion of HeLa cells through modulating MAPK1.
Zhu L; Yang S; Wang J
Int J Mol Med; 2019 Nov; 44(5):1824-1832. PubMed ID: 31485607
[TBL] [Abstract][Full Text] [Related]
8. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.
Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
Cardiovasc Pathol; 2018; 33():6-15. PubMed ID: 29268138
[TBL] [Abstract][Full Text] [Related]
9. Salsalate ameliorates the atherosclerotic response through HO-1- and SIRT1-mediated suppression of ER stress and inflammation.
Jung TW; Park HS; Jeong JH; Lee T
Inflamm Res; 2019 Aug; 68(8):655-663. PubMed ID: 31143972
[TBL] [Abstract][Full Text] [Related]
10. SESN1 attenuates the Ox‑LDL‑induced inflammation, apoptosis and endothelial‑mesenchymal transition of human umbilical vein endothelial cells by regulating AMPK/SIRT1/LOX1 signaling.
Gao F; Zhao Y; Zhang B; Xiao C; Sun Z; Gao Y; Dou X
Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35293601
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of miR‑34a prevents endothelial cell apoptosis by directly targeting HDAC1 in the setting of atherosclerosis.
Li Y; Zhang K; Mao W
Mol Med Rep; 2018 Mar; 17(3):4645-4650. PubMed ID: 29328474
[TBL] [Abstract][Full Text] [Related]
12. PM
Zhong Y; Liao J; Hu Y; Wang Y; Sun C; Zhang C; Wang G
Int J Med Sci; 2019; 16(3):384-393. PubMed ID: 30911272
[No Abstract] [Full Text] [Related]
13. SIRT1 prevents atherosclerosis via liver‑X‑receptor and NF‑κB signaling in a U937 cell model.
Zeng HT; Fu YC; Yu W; Lin JM; Zhou L; Liu L; Wang W
Mol Med Rep; 2013 Jul; 8(1):23-8. PubMed ID: 23652462
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages.
Chen T; Huang Z; Wang L; Wang Y; Wu F; Meng S; Wang C
Cardiovasc Res; 2009 Jul; 83(1):131-9. PubMed ID: 19377067
[TBL] [Abstract][Full Text] [Related]
15. miR-9-5p modulates the progression of Parkinson's disease by targeting SIRT1.
Wang Z; Sun L; Jia K; Wang H; Wang X
Neurosci Lett; 2019 May; 701():226-233. PubMed ID: 30826419
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of microRNA‑124‑3p protects against acute myocardial infarction by suppressing the apoptosis of cardiomyocytes.
Hu G; Ma L; Dong F; Hu X; Liu S; Sun H
Mol Med Rep; 2019 Oct; 20(4):3379-3387. PubMed ID: 31432169
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-3188 targets ETS-domain protein 4 and participates in RhoA/ROCK pathway to regulate the development of atherosclerosis.
Li N; Chen J; Zhao J; Wang T
Pharmazie; 2017 Nov; 72(11):687-693. PubMed ID: 29442044
[TBL] [Abstract][Full Text] [Related]
18. miR-497 accelerates oxidized low-density lipoprotein-induced lipid accumulation in macrophages by repressing the expression of apelin.
Cui J; Ren Z; Zou W; Jiang Y
Cell Biol Int; 2017 Sep; 41(9):1012-1019. PubMed ID: 28653788
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice.
Xie W; Li L; Zhang M; Cheng HP; Gong D; Lv YC; Yao F; He PP; Ouyang XP; Lan G; Liu D; Zhao ZW; Tan YL; Zheng XL; Yin WD; Tang CK
PLoS One; 2016; 11(6):e0157085. PubMed ID: 27257686
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-24 aggravates atherosclerosis by inhibiting selective lipid uptake from HDL cholesterol via the post-transcriptional repression of scavenger receptor class B type I.
Ren K; Zhu X; Zheng Z; Mo ZC; Peng XS; Zeng YZ; Ou HX; Zhang QH; Qi HZ; Zhao GJ; Yi GH
Atherosclerosis; 2018 Mar; 270():57-67. PubMed ID: 29407889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
